Cross Country Healthcare Issues Non-Binding Press Release
Cross Country Healthcare to Attend the Morgan Stanley 22nd Annual Global Healthcare Conference and the 17th Annual Barrington Research Virtual Fall Investment Conference
There May Be Reason For Hope In Cross Country Healthcare's (NASDAQ:CCRN) Disappointing Earnings
Cross Country Healthcare Is Maintained at Outperform by Barrington Research
Barrington Research Adjusts Cross Country Healthcare's PT to $19 From $21, Keeps Outperform Rating
Results: Cross Country Healthcare, Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Cross Country Healthcare Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Cross Country Healthcare | 10-Q: Q2 2024 Earnings Report
There's No Escaping Cross Country Healthcare, Inc.'s (NASDAQ:CCRN) Muted Earnings Despite A 34% Share Price Rise
Truist Securities Maintains Hold on Cross Country Healthcare, Raises Price Target to $17
Cross Country Healthcare Analyst Ratings
Oppenheimer Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Benchmark Co. Maintains Cross Country Healthcare(CCRN.US) With Buy Rating, Maintains Target Price $19
Cross Country Healthcare (CCRN) Receives a Rating Update From a Top Analyst
Express News | Cross Country Healthcare Inc : Truist Securities Raises Target Price to $17 From $16
JMP Securities Maintains Cross Country Healthcare(CCRN.US) With Hold Rating
Cross Country Healthcare, Inc. (CCRN) Q2 2024 Earnings Call Transcript
Express News | Cross Country Healthcare Inc Q3 Shr View $0.16, Rev View $328.2 Mln -- LSEG IBES Data
Express News | Cross Country Healthcare Inc: Sees Q3 Revenue $305 Mln - $315 Mln
Cross Country Healthcare Issues Crucial Stakeholder Update
No Data